Amgen Inc. (AMGN) - 5i Research

Amgen Inc. (AMGN $292.51)
- $292.51 Fwd P/E: 27.08X Cap: $159.71B
- View AMGN Profile
- View Questions on AMGN

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Amgen Inc. (AMGN $292.51)
- $292.51 Fwd P/E: 27.08X Cap: $159.71B
- View AMGN Profile
- View Questions on AMGN

Q: Hi there,

Do you think AMGN is a good buy right now for future growth and income? What are the pros and cons?

Ok thank you!

Read Answer Asked by Robert on June 23, 2025

Amgen Inc. (AMGN $292.51)
- $292.51 Fwd P/E: 27.08X Cap: $159.71B
- View AMGN Profile
- View Questions on AMGN
Biogen Inc. (BIIB $127.50)
- $127.50 Fwd P/E: 13.15X Cap: $19.50B
- View BIIB Profile
- View Questions on BIIB
Gilead Sciences Inc. (GILD $109.06)
- $109.06 Fwd P/E: 23.55X Cap: $139.43B
- View GILD Profile
- View Questions on GILD
Intuitive Surgical Inc. (ISRG $512.23)
- $512.23 Fwd P/E: 75.61X Cap: $183.53B
- View ISRG Profile
- View Questions on ISRG
AbbVie Inc. (ABBV $186.39)
- $186.39 Fwd P/E: 81.85X Cap: $335.40B
- View ABBV Profile
- View Questions on ABBV
Eli Lilly and Company (LLY $771.75)
- $771.75 Fwd P/E: 65.04X Cap: $757.56B
- View LLY Profile
- View Questions on LLY

Q: Do you have any suggestions re the Pharma companies which would be a good time to purchase now, either in a partial or full position? Thanks

Read Answer Asked by FORREST on March 21, 2025

Amgen Inc. (AMGN $292.51)
- $292.51 Fwd P/E: 27.08X Cap: $159.71B
- View AMGN Profile
- View Questions on AMGN
Merck & Company Inc. (MRK $81.52)
- $81.52 Fwd P/E: 12.19X Cap: $210.09B
- View MRK Profile
- View Questions on MRK
AbbVie Inc 0.500% Senior Notes 2021 (ABBV.21C)
- Fwd P/E: 44.76X
- View ABBV.21C Profile
- View Questions on ABBV.21C
Harvest Healthcare Leaders Enhanced Income ETF (HHLE $8.46)
- $8.46 Fwd P/E: 28.54X Cap: $28M
- View HHLE Profile
- View Questions on HHLE

Q: Hello 5i, I am up quite a bit on MRK, ABBVIE and HHLE. In answer to a question on MRK by Michael on Jan 22 you wrote "We would take a look at AMGN as an alternative to MRK". With the success I have with MRK et al. is MRK a sell to be replaced by AMGN now or is MRK still a keeper for now. Value investor.
Stanley

Read Answer Asked by STANLEY on January 23, 2025